Critical Biologics (Cambridge, MA) developer of therapeutics for critical-care patients with low plasma gelsolin, has raised $7 million in Series A funding from Morningside Ventures.
Critical Biologics, Corp.: Series A $7M
March 2, 2007
Leave a Comment » | 
I - Series A, R - NORTH EAST, X - Plasma | 
Permalink
Posted by arubenstein
